A case report of intracranial hemorrhage after spinal anesthesia by Yuri Iwase et al.
CASE REPORT Open Access
A case report of intracranial hemorrhage
after spinal anesthesia
Yuri Iwase, Manzo Suzuki* and Hiroyasu Bito
Abstract
Background: Chronic subdural hematoma (CSDH) after spinal anesthesia is a rare complication. We experienced a
patient who developed CSDH after postdural puncture headache (PDPH) following combined spinal and epidural
anesthesia (CSE).
Case presentation: A 38-week-gestation parturient with a history of previous cesarean delivery underwent elective
cesarean section under CSE. She had been receiving aspirin therapy for Kawasaki disease for many years. She developed
a symptom of PDPH 1 day after the surgery. Fluid administration and analgesics were started. Although the headache
was relatively severe and persistent, it suddenly disappeared on the third postoperative day. Aspirin administration was
restarted on the third postoperative day, and the patient was discharged 1 week after the surgery. 2 weeks after being
discharged, she was readmitted to our hospital for severe headache and was diagnosed as having CSDH. An epidural
blood patch was performed, resulting in resolution of the hematoma.
Conclusions: We experienced a case of CSDH after PDPH in a patient who was receiving aspirin therapy. Aspirin therapy
should be restarted after confirmation of the absence of headache. We should consider the possibility of unexpected
disappearance of PDPH in the postoperative period may be due to the development of CSDH.
Keywords: Chronic subdural hematoma, Postdural puncture headache, Combined spinal and epidural anesthesia,
Aspirin
Background
Postdural puncture headache (PDPH) is a benign condi-
tion and a frequent complication associated with neuraxial
anesthesia. Intracranial chronic subdural hematoma
(CSDH) is a rare but lethal complication following
PDPH. More than 50 cases of subdural hematoma after
neuraxial anesthesia or dural puncture have been reported
[1, 2]. We experienced a case of CSDH after cesarean
delivery.
Case presentation
A 34-year-old parturient with a history of previous
cesarean delivery underwent elective cesarean delivery at
38 weeks gestation. She was taking aspirin, 100 mg per
day, for Kawasaki disease. The results of preoperative
blood examination including platelet count, prothrombin
time, and activated prothromboplastin time, were normal.
After one-week cessation of aspirin therapy, an uneventful
cesarean delivery was performed under combined spinal
and epidural anesthesia (CSEA). Epidural catheterization
was performed using an 18-gauge Tuohy needle (UNIVER,
UNISYS, Saitama, Japan) through the Th12/L1 interspace.
A catheter for epidural anesthesia was inserted without any
complications. Spinal anesthesia was performed using a 25-
gauge Quincke needle (UNISYS) at the L/3/4 interspace. A
bolus of isobaric 0.5% bupivacaine, 2.2 ml, was injected,
and a dermatomal level of sensory block at the level of
Th10 was confirmed by alcohol swab. During the surgery,
0.25% levobupivacaine, 5 ml, was administered through the
epidural catheter. After the surgery, a dermatomal level of
sensory block at the level of Th6 was confirmed. Postopera-
tive analgesia was obtained by epidural infusion of 0.25%
levobupivacaine containing 10 μg of fentanyl at the rate of
4 ml/h. 1 day after the surgery, she had an occipital head-
ache while in the sitting position with neck stiffness and
back pain. Intravenous fluid administration, 1000 ml/day,
and administration of loxoprofen, 60 mg three times a day,
were started the day after surgery. Although the headache
was relatively severe and seemed to be persistent, her
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headache suddenly disappeared on the third postoperative
day. The patient recovered and she could walk around the
ward on the fifth postoperative day. Administration of
aspirin was restarted on the third day after the surgery by
her obstetrician, and the decision to restart aspirin therapy
was not based on disappearance of PDPH but just on their
routine procedure. 1 week after the surgery, the patient was
discharged from the hospital without significant symptoms.
2 weeks after hospital discharge, she presented to the
emergency room with a severe headache, the severity of
which was not related to her position. She complained
that light headache had reappeared 3 days after being
discharged, and the headache worsened over the next
10 days. Computed tomography (CT) showed an ipsilateral
chronic subdural hematoma (Fig. 1). The patient was
admitted to the hospital and aspirin therapy was stopped.
While she had been staying in bed in the hospital, she
complained of having a light headache without neuro-
logical deficits. After one-week cessation of aspirin admin-
istration, an epidural blood patch was performed. Surgical
resection of the hematoma was scheduled as a back-up
plan in case her headache became severe or neurological
symptoms developed. During injection of 15 ml of blood
in the L4/5 interspace using an 18-gauge Tuohy needle,
she complained of light headache, which disappeared 1 h
after the procedure. She was told to stay in bed for 1 week
after the epidural blood patch. One week after the
procedure, CT showed resolution of the hematoma (Fig. 2).
Administration of aspirin was restarted 9 days after the
procedure. The patient was discharged from the hospital
13 days after the procedure. The patient has not developed
any further symptoms.
Discussion
We experienced a patient who developed CSDH after
combined spinal and epidural anesthesia for cesarean
delivery. She developed a headache 1 day after the
surgery which was suspected as being PDPH since she
also had neck stiffness and back pain. However, the
possibility of acute subdural hematoma soon after the
surgery remained. Macon et al. [3] stated that a head-
ache that persists and is more severe than PDPH may be
due to acute subdural hematoma. Yildirim et al. [4]
reported a patient with acute subdural hematoma that
had been misdiagnosed as eclampsia. The development
of an acute subdural hematoma soon after delivery pre-
sents a very fast time course and results in coma [4–6].
In the present case, although her headache was relatively
severe and seemed to be persistent, it disappeared sud-
denly on the third postoperative day. This time course
including temporal improvement of the headache sug-
gested that the headache was not due to development of
acute intracranial hemorrhage soon after the surgery,
but that it was due to dural puncture.
Many case reports suggested the mechanism of the
development of CSDH following PDPH [1, 2, 7]. Some
reports suggested that temporal disappearance of head-
ache or a fatal outcome was due to development of a
hematoma [2, 4]. Leakage of cerebrospinal fluid (CSF)
from a dural hole leads to reduced volume of CSF and
results in a decrease in intraspinal and intracranial pres-
sure. The change in cerebrospinal dynamics induces
caudal movement of the spinal cord and brain which
results in stretching of the dura, cranial nerve, and
bridging vein, which in turn causes headache and bleed-
ing from the vein [7]. The increase in intracranial pres-
sure by the progression of intracranial hematoma may
compensate the decrease in intracranial pressure by
spinal fluid leakage. The unexpected disappearance of
Fig. 1 Computed tomogram obtained at the time of readmission to
the emergency room. A subdural hematoma (arrow) is seen
Fig. 2 1 week after epidural blood patch was performed, computed
tomogram shows resolution of the subdural hematoma (arrow)
Iwase et al. JA Clinical Reports  (2017) 3:11 Page 2 of 4
PDPH in the present case may have been due to pro-
gression of the formation of an intracranial lesion.
Nakannuno demonstrated that 40% of case in CSDH
after PDPH presented the time course which includes
temporal disappearance of headache such as present
case [1].
In several cases, administration of antiplatelets or anti-
coagulants had been suspected to be related to the
development of PDPH [8–10]. Landman et al. [9] reported
a case of CSDH in a patient who had self-administered
aspirin and caffeine for the treatment of PDPH. There are
two case reports of CSDH after improvement of PDPH in
patients who received heparin infusion for thrombopro-
phylaxis [10, 11]. In a parturient who developed CSDH
after PDPH following cesarean delivery, the physicians
hesitated in administering an epidural blood patch
because she had thrombocytopenia due to HELLP syn-
drome [12]. In the present case, the patient had been
taking aspirin for Kawasaki disease, and aspirin admin-
istration was restarted on the third postoperative day.
Meta-analyses that examined both the primary and the
secondary benefits of aspirin indicated that the risk of
intracranial bleeding increased in a trial examining the
primary benefit of aspirin in preventing cardiovascular
disease, whereas the risk of intracranial bleeding did
not increase in a trial that demonstrated the secondary
benefit of aspirin in preventing cardiovascular disease
[13, 14]. In healthy women, administration of aspirin
does not increase the risk of intracranial bleeding [15].
One article that estimated the pooled relative risk of
intracranial bleeding, demonstrated that long-term
administration of aspirin increased the risk of intracranial
bleeding, although the risk was still small [16]. However,
among patients who developed intracranial bleeding,
patients who had been taking aspirin possessed high
mortality [17]. In the present case, even though the patient’s
headache had improved at the time of restarting aspirin
therapy, there remained a possibility that the improvement
was a result of compensation of intracranial hypotension by
the formation of a hematoma, and administration of aspirin
may have worsened the degree of bleeding. Even though
administration of aspirin may not have been the direct
cause of the development of bleeding because aspirin was
not administered in the perioperative period, the develop-
ment of an antiplatelet effect may have contributed to the
development of the hematoma. In the presence of intracra-
nial hypotension, patients who are taking aspirin may be at
high risk for intracranial bleeding.
In the present case, epidural blood patch was adminis-
tered for the treatment of CSDH. Various treatments for
CSDH after PDPH have been reported including observa-
tion, surgical resection of the hematoma, epidural blood
patch, or both surgical resection and epidural blood patch
[7, 8, 18, 19]. The treatment plan is decided according to
the patient’s neurological symptoms and the size of the
hematoma. In the present case, the patient complained of
headache without neurological deficits, thus epidural
blood patch was performed, considering surgical resection
as a back-up plan. In the case of CSDH after PDPH, there
is a possibility of recurrence of bleeding by only surgical
drainage because the underlying cause of intracranial
hypotension remains [20].
The guidelines of the American Society of Regional
Anesthesia state that aspirin administration does not
have to be suspended prior to administration of neuraxial
anesthesia, in cases where aspirin is self-administered [21].
However, this recommendation is based on the assumption
that a spinal or epidural hematoma develops only around
the site of spinal or epidural puncture. Although the
development of CSDH after PDPH following neuraxial
anesthesia is rare, it is sometimes fatal. In the present
case, the timing of when to restart aspirin therapy had
been decided by her obstetrician. In present case, an
anesthesiologist may be better to be involved in the
decision of restart in antiplatelet therapy. This case report
indicates that antiplatelet and anticoagulation therapy
should be restarted after confirming that the patient does
not have PDPH following neuraxial anesthesia. Antiplatelet
and anticoagulation therapy should also be restarted after
confirming that unexpected disappearance of PDPH is not
due to the development of CSDH by CT imaging.
Conclusions
We experienced a case of CSDH after PDPH in a patient
who underwent neuraxial anesthesia. The patient was
receiving aspirin therapy for Kawasaki disease. She
underwent surgery after cessation of aspirin therapy
for 1 week. It may be better to restart aspirin therapy
after confirming the absence of PDPH after surgery.
We should consider the possibility of unexpected dis-
appearance of PDPH in the postoperative period may
be due to the development of CSDH. Although inci-
dence of CSDH after PDPH is rare, we believe that we
may be better to confirm the absence of CSDH by CT
before restart of aspirin therapy.
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